Related Experiment Videos
[Resistant antibiotic analysis of methicillin-resistant staphylococcus]
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|February 23, 2000
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of hospital infections. This study found MRSA strains exhibit high resistance to common antibiotics, suggesting vancomycin and nitrofurantoin as preferred treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Nosocomial infections are frequently caused by pathogenic bacteria like Staphylococcus aureus.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings.
- Understanding antibiotic resistance patterns is crucial for effective infection control and treatment strategies.
Purpose of the Study:
- To determine the antibiotic resistance rates of Staphylococcus strains, focusing on methicillin resistance.
- To investigate the prevalence of beta-lactamase production in Staphylococcus strains.
- To provide data supporting the selection of appropriate antibiotics for treating Staphylococcus-related infections.
Main Methods:
- Testing 88 Staphylococcus strains for resistance to methicillin and 14 other common antibiotics.
- Assessing beta-lactamase enzyme production in the tested strains.
- Analyzing resistance rates and multi-drug resistance profiles.
Main Results:
- The isolation rate of MRSA was 56%, and methicillin-resistant coagulase-negative Staphylococcus (MRSCoN) was 47.6%.
- Methicillin-resistant Staphylococcus (MRS) strains showed higher resistance and multi-resistance rates compared to methicillin-sensitive strains.
- MRSA exhibited the highest beta-lactamase production (92.9%), while methicillin-sensitive coagulase-negative Staphylococcus (MSSCoN) had the lowest (39.4%).
Conclusions:
- Methicillin-resistant Staphylococcus strains demonstrate significant multi-drug resistance.
- Vancomycin and nitrofurantoin are identified as sensitive options for treating methicillin-resistant Staphylococcus.
- These findings support prioritizing vancomycin and nitrofurantoin in clinical treatment protocols for these infections.